Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
 arrow  CME course
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Published comments/rapid response letters
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Collins, J. F.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice

right arrow Judith F. Collins, MD; David A. Lieberman, MD; Theodore E. Durbin, MD; David G. Weiss, PhD, and the Veterans Affairs Cooperative Study #380 Group*

18 January 2005 | Volume 142 Issue 2 | Pages 81-85

Background: Many expert panels recommend colorectal cancer screening for average-risk asymptomatic individuals older than 50 years of age. Recent studies have found that 24% to 64% of primary care providers use only the digital fecal occult blood test (FOBT) as their primary screening test. The effectiveness of a single digital FOBT is unknown.

Objective: To compare the sensitivity and specificity of digital FOBT and the recommended 6-sample at-home FOBT for advanced neoplasia in asymptomatic persons.

Design: Prospective cohort study.

Setting: 13 Veterans Affairs medical centers.

Patients: 3121 asymptomatic patients 50 to 75 years of age.

Intervention: 2665 patients had 6-sample at-home FOBT and digital FOBT, followed by complete colonoscopy.

Measurements: We measured the sensitivity of digital and 6-sample FOBT for advanced neoplasia and the specificity for no neoplasia. We calculated predictive values and likelihood ratios for advanced neoplasia, defined as tubular adenomas 10 mm or greater, adenomas with villous histology or high-grade dysplasia, or invasive cancer.

Results: Of all participants, 96.8% were men; their average age was 63.1 years. The 6-sample FOBT and the single digital FOBT had specificities of 93.9% and 97.5%, respectively, as defined by studying 1656 patients with no neoplasia. Sensitivities for detection of advanced neoplasia in 284 patients were 23.9% for the 6-sample FOBT and 4.9% for the digital FOBT. The likelihood ratio for advanced neoplasia was 1.68 (95% CI, 0.96 to 2.94) for positive results on digital FOBT and 0.98 (CI, 0.95 to 1.01) for negative results.

Limitations: Most patients were men.

Conclusions: Single digital FOBT is a poor screening method for colorectal neoplasia and cannot be recommended as the only test. When digital FOBT is performed as part of a primary care physical examination, negative results do not decrease the odds of advanced neoplasia. Persons with these results should be offered at-home 6-sample FOBT or another type of screening test.


Editors' Notes
space

Context

  • Many physicians screen for advanced colonic neoplasia by testing the stool obtained from a digital rectal examination for occult blood.

Contribution

  • The authors performed fecal occult blood tests (FOBTs) on samples from digital rectal examination and did complete optical colonoscopy on 2665 average-risk asymptomatic adults. The sensitivity and specificity of digital FOBT for advanced colonic neoplasia were 4.9% and 97.1%, respectively. The positive and negative likelihood ratios were 1.68 and 0.98, respectively.

Implications

  • A negative result on a test for fecal occult blood in a digital rectal sample does not change the odds of advanced colonic neoplasia. Physicians should not rely on FOBT performed on a single sample of stool.

–The Editors

 

Author and Article Information
space

From Department of Veterans Affairs Medical Centers, Portland, Oregon, Long Beach, California, and Perry Point, Maryland.

*For a list of members of the Veterans Affairs Cooperative Study #380 Group, see the Appendix.

Grant Support: By the Cooperative Studies Program, Department of Veterans Affairs, Protocol #380.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Judith F. Collins, MD, Portland Veterans Affairs Medical Center, P3-GI, 3710 SW Veterans Hospital Road, PO Box 1034, Portland, OR 97239.

Current Author Addresses: Drs. Collins and Lieberman: Portland Veterans Affairs Medical Center, P3-GI, 3710 SW Veterans Hospital Road, PO Box 1034, Portland, OR 97239.

Dr. Durbin: West Anaheim Medical Offices, Suite 203, 3010 West Orange Street, Anaheim, CA 92804.

Dr. Weiss: Perry Point Veterans Affairs Medical Center, 151E, PO Box 1010, Perry Point, MD 21902.

Author Contributions: Conception and design: D.A. Lieberman, D.G. Weiss.

Analysis and interpretation of the data: J.F. Collins, D.A. Lieberman, T.E. Durbin, D.G. Weiss.

Drafting of the article: J.F. Collins, D.A. Lieberman, T.E. Durbin.

Critical revision of the article for important intellectual content: J.F. Collins, D.A. Lieberman, D.G. Weiss.

Final approval of the article: J.F. Collins, D.A. Lieberman, T.E. Durbin, D.G. Weiss.

Provision of study materials or patients: J.F. Collins, D.A. Lieberman, T.E. Durbin.

Statistical expertise: D.A. Lieberman, D.G. Weiss.

Obtaining of funding: D.A. Lieberman, D.G. Weiss.

Administrative, technical, or logistic support: D.G. Weiss.

Collection and assembly of data: J.F. Collins, D.A. Lieberman, T.E. Durbin, D.G. Weiss.


Related articles in Annals:

Editorials
Office-Based Testing for Fecal Occult Blood: Do Only in Case of Emergency
Harold C. Sox
Annals 2005 142: 146-148. [Full Text]  

Articles
A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood
Marion R. Nadel, Jean A. Shapiro, Carrie N. Klabunde, Laura C. Seeff, Robert Uhler, Robert A. Smith, AND David F. Ransohoff
Annals 2005 142: 86-94. [ABSTRACT][SUMMARY][Full Text]  

Summaries for Patients
What Is the Best Way To Test for Colorectal Cancer?
Annals 2005 142: I-23. [Full Text]  

Letters
Accuracy of a Single Fecal Occult Blood Test in Screening for Colorectal Cancer
Robert C. Kane
Annals 2005 143: 235. [Full Text]  

Letters
Office-Based Testing for Fecal Occult Blood
Michael L. Wolff
Annals 2005 143: 235. [Full Text]  

Letters
Office-Based Testing for Fecal Occult Blood
Christian Jackson AND Robert Craig
Annals 2005 143: 235-236. [Full Text]  

Letters
Office-Based Testing for Fecal Occult Blood
Harold C. Sox
Annals 2005 143: 236. [Full Text]  



This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
D. A. Ahlquist, D. J. Sargent, C. L. Loprinzi, T. R. Levin, D. K. Rex, D. J. Ahnen, K. Knigge, M. P. Lance, L. J. Burgart, S. R. Hamilton, et al.
Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
Ann Intern Med, October 7, 2008; 149(7): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
B. Levin, D. A. Lieberman, B. McFarland, R. A. Smith, D. Brooks, K. S. Andrews, C. Dash, F. M. Giardiello, S. Glick, T. R. Levin, et al.
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
CA Cancer J Clin, May 1, 2008; 58(3): 130 - 160.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and O. W. Brawley
Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues
CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
C. G Fraser
Faecal occult blood tests - eliminate, enhance or update?
Ann Clin Biochem, March 1, 2008; 45(2): 117 - 121.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. E. Allison, L. C. Sakoda, T. R. Levin, J. P. Tucker, I. S. Tekawa, T. Cuff, M. P. Pauly, L. Shlager, A. M. Palitz, W. K. Zhao, et al.
Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics
J Natl Cancer Inst, October 3, 2007; 99(19): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and H. J. Eyre
Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects
CA Cancer J Clin, March 1, 2007; 57(2): 90 - 104.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
Z. Levi, P. Rozen, R. Hazazi, A. Vilkin, A. Waked, E. Maoz, S. Birkenfeld, M. Leshno, and Y. Niv
A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal Neoplasia
Ann Intern Med, February 20, 2007; 146(4): 244 - 255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
C. E. Basch, R. L. Wolf, C. H. Brouse, C. Shmukler, A. Neugut, L. T. DeCarlo, and S. Shea
Telephone Outreach to Increase Colorectal Cancer Screening in an Urban Minority Population
Am J Public Health, December 1, 2006; 96(12): 2246 - 2253.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. B. El-Serag, L. Petersen, H. Hampel, P. Richardson, and G. Cooper
The use of screening colonoscopy for patients cared for by the department of veterans affairs.
Arch Intern Med, November 13, 2006; 166(20): 2202 - 2208.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Roessler, W. Rollinger, L. Mantovani-Endl, M.-L. Hagmann, S. Palme, P. Berndt, A. M. Engel, M. Pfeffer, J. Karl, H. Bodenmuller, et al.
Identification of PSME3 as a Novel Serum Tumor Marker for Colorectal Cancer by Combining Two-dimensional Polyacrylamide Gel Electrophoresis with a Strictly Mass Spectrometry-based Approach for Data Analysis
Mol. Cell. Proteomics, November 1, 2006; 5(11): 2092 - 2101.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
N. J. Greenberger and P. Sharma
Update in Gastroenterology and Hepatology
Ann Intern Med, August 15, 2006; 145(4): 294 - 298.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. R. Martinez, S. E. Young, R. E. Hoedema, L. J. Foshag, and A. J. Bilchik
Colorectal Cancer Screening and Surveillance: Current Standards and Future Trends
Ann. Surg. Oncol., June 1, 2006; 13(6): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
W. C. Taylor
A 71-Year-Old Woman Contemplating a Screening Colonoscopy
JAMA, March 8, 2006; 295(10): 1161 - 1167.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and H. J. Eyre
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
CA Cancer J Clin, January 1, 2006; 56(1): 11 - 25.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Roessler, W. Rollinger, S. Palme, M.-L. Hagmann, P. Berndt, A. M. Engel, B. Schneidinger, M. Pfeffer, H. Andres, J. Karl, et al.
Identification of Nicotinamide N-Methyltransferase as a Novel Serum Tumor Marker for Colorectal Cancer
Clin. Cancer Res., September 15, 2005; 11(18): 6550 - 6557.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. E. Brenner and G. Rennert
Fecal DNA Biomarkers for the Detection of Colorectal Neoplasia: Attractive, but Is It Feasible?
J Natl Cancer Inst, August 3, 2005; 97(15): 1107 - 1109.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. C. Kane
Accuracy of a Single Fecal Occult Blood Test in Screening for Colorectal Cancer
Ann Intern Med, August 2, 2005; 143(3): 235 - 235.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. L. Wolff
Office-Based Testing for Fecal Occult Blood
Ann Intern Med, August 2, 2005; 143(3): 235 - 235.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. Jackson and R. Craig
Office-Based Testing for Fecal Occult Blood
Ann Intern Med, August 2, 2005; 143(3): 235 - 236.
[Full Text] [PDF]


Home page
JAMAHome page
H. H. Pham, D. Schrag, J. L. Hargraves, and P. B. Bach
Delivery of Preventive Services to Older Adults by Primary Care Physicians
JAMA, July 27, 2005; 294(4): 473 - 481.
[Abstract] [Full Text] [PDF]


Home page
JWatch Women's HealthHome page
DRE-Based FOBT: Common but Not Useful
Journal Watch Women's Health, February 22, 2005; 2005(222): 8 - 8.
[Full Text]


Home page
JWatch GastroenterologyHome page
Digital FOBT Often Used but Very Insensitive
Journal Watch Gastroenterology, February 16, 2005; 2005(216): 7 - 7.
[Full Text]


Home page
JWatch GeneralHome page
DRE-Based FOBT: Common but Not Useful
Journal Watch (General), February 1, 2005; 2005(201): 1 - 1.
[Full Text]


Home page
ANN INTERN MEDHome page
M. R. Nadel, J. A. Shapiro, C. N. Klabunde, L. C. Seeff, R. Uhler, R. A. Smith, and D. F. Ransohoff
A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood
Ann Intern Med, January 18, 2005; 142(2): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. C. Sox
Office-Based Testing for Fecal Occult Blood: Do Only in Case of Emergency
Ann Intern Med, January 18, 2005; 142(2): 146 - 148.
[Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Another Perspective
Robert C. Kane
Annals Online, 20 Jan 2005 [Full text]
In defense of the digital rectal exam and FOBT
Christopher A Smith
Annals Online, 22 Feb 2005 [Full text]
The Role of the Fecal Occult Blood Test
Christian Jackson, et al.
Annals Online, 28 Feb 2005 [Full text]



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2005 by the American College of Physicians.